Join us at eCheminfo Euro

eChemInfo workshop

Final Announcement for the eChemInfo Training and Innovation Course in Drug Design 2017 in Milano

This is a final eminder that the Training and Innovation Course in Drug Design will take place at the Department of Pharmaceutical Sciences, University of Milano from Mon, 17 Jul. to Fri, 21 Jul. 2017.

The final program is available at http://www.echeminfo.com/events/drug-design-euro-2017

We will have three exiting key notes:

  • Malaria Drug Discovery Methods, Donatella Taramelli, University of Milan
  • Aspects of Industrial Drug Design, Anna Maria Capelli, Chiesi
  • Design of Cyclopeptidic Drugs, Laura Belvisi / Monica Civera, University of Milan

We are also very happy to be able this year to strongly integrate experimental techniques into the workshop. Stefan Jehle from Bruker BioSpin AG, the leading company in biomolecular NMR spectroscopy, will give a session on “NMR-driven Fragment Based Drug Design”. And we have Anthony Bradley from the Diamond Light Source's XChem project, which provides services for complex structure determination using medium- to high-throughput X-ray. He will give a presentation together with Tim Dudgeon (Informatics Matters) on “Moving from Individual Tools to Complete Workflows”.

And just to remind you on our special setup of the workshop: Use the “bring your own problems” option to directly apply your newly acquired knowledge to your own research, profit from specific advice by the experts and other participants and contribute to innovative approaches for all case studies. You can also present a poster of your work to give the other attendees an overview of your work and foster discussions within the groups.

We would highly appreciate if you could showcase the workshop poster (http://www.echeminfo.com/Milano2017_Poster.pdf) on your notice boards.

Register now at https://goo.gl/au4QBW

 

Dr Thomas Exner is a Chief Scientific Officer (CSO) at Douglas Connect

 

Add new comment

By submitting this form, you accept the Mollom privacy policy.

About Douglas Connect

Douglas Connect manages collaborative projects to achieve goals in scientific research, infrastructure development or service provision. Effective collaboration requires many elements including coordination, culture, communications, common understanding, decision-making and interoperability.

Tags

Latest Tweets

Douglas Connect (3 days ago)
"Save the dates for OpenTox Euro 2017 Meeting" https://t.co/muWLfrAPZb on @LinkedIn
Douglas Connect (5 days ago)
RT @EU_ToxRisk: Global Summit on Regulatory Science ANVISA Brazil Sept.18-20, 2017 #Drug #FoodSafety #FDA #JRC @EFSA_EU @DouglasConn https:…
Douglas Connect (1 week ago)
Advancing reproducible regulatory science and practice #reproducibility #GSRS17 #RegulatoryScience… https://t.co/DmkFYO98kD
Douglas Connect (2 weeks ago)
RT @barryhardy: Working together on Safety Assessment - a Model for Collaboration @DouglasConn stand 41 #ToxHQ #EuroTox2017 https://t.co/Y0…
Douglas Connect (2 weeks ago)
RT @barryhardy: #Integrated #Testing #Strategy #Skin #Sensitization Application available for Evaluation #EuroTox2017 Douglas Connect stand…

Get in touch

  • Address: Douglas Connect GmbH
    Technology Park Basel
    Hochbergerstrasse 60C
    CH-4057 Basel / Basel-Stadt
    Switzerland
  • Phone: +41 61 851 0170
  • Email: info@douglasconnect.com